Peroxynitrite (ONOO -) strongly inhibits agonist-induced platelet responses. However, the mechanisms involved are not completely defined. Using porcine platelets, we tested the hypothesis that ONOO -reduces platelet aggregation and dense granule secretion by inhibiting energy production. It was found that ONOO -(25-300 µM) inhibited collagen-induced dense granule secretion (IC 50 = 55 ± 7 µM) more strongly than aggregation (IC 50 = 124 ± 16 µM). The antiaggregatory and antisecretory effects of ONOO -were only slightly (5-10%) reduced by 1H-[1,2,4]-oxadiazolo-[4,3-α]quinoxalin-1-one (ODQ), an inhibitor of soluble guanylate cyclase. In resting platelets ONOO -(50-300 µM) enhanced glycolysis rate and reduced oxygen consumption, in a dose dependent manner. The ONOO -effects on glycolysis rate and oxygen consumption were not abolished by ODQ. The extent of glycolysis stimulation exerted by ONOO -was similar to that produced by respiratory chain inhibitors (cyanide and antimycin A) or an uncoupler (2,4-dinitrophenol). Stimulation of platelets by collagen was associated with a rise in mitochondrial oxygen consumption, accelerated lactate production, and unchanged intracellular ATP content. In contrast to resting cells, in collagen-stimulated platelets, ONOO -(200 µM) distinctly decreased the cellular ATP content. The glycolytic activity and oxygen consumption of resting platelets were not affected by 8-bromoguanosine 3',5'-cyclic monophosphate. Blocking of the mitochondrial ATP production by antimycin A slightly reduced collagen-induced aggregation and strongly inhibited dense granule secretion. Treatment of platelets with ONOO -(50-300 µM) resulted in decreased activities of NADH : ubiquinone oxidoreductase, succinate dehydrogenase and cytochrome oxidase. It is concluded that the inhibitory effect of ONOO -on platelet secretion and to a lesser extent on aggregation may be mediated, at least in part, by the reduction of mitochondrial energy production.
INTrODUCTION
Peroxynitrite (ONOO -, oxoperoxonitrate (-1)) is a potent oxidant and nitrating agent formed by the rapid reaction between superoxide (O 2
•-) and nitric oxide (NO) Murphy et al., 1998) . Formation of large quantities of ONOO -is expected to occur during ischemia-reperfusion injury, sepsis, neurodegenerative diseases and inflammatory processes where NO and O 2
•-production is elevated (Radi et al., 2001) . The main source of ONOO -in blood stream are activated circulating inflammatory cells, e.g. neutrophiles and monocytes (Ischiropoulos et al., 1992) . Activated platelets may also release small amounts of ONOO -since they have been proposed to generate both NO and O 2
•- (Malinski et al., 1993; Marcus et al., 1997; Boulos et al., 2000) . Appearing in the blood stream, ONOO -is therefore likely to interact with platelets. In vitro micromolar concentrations of ONOO -are able to affect some platelet responses (Moro et al., 1994; Boulos et al., 2000; Nowak & Wachowicz, 2001 ). However, the results of those studies are conflicting. It has been reported that ONOO -may either strongly reduce platelet responses or behave as an inducer of their aggregation (Moro et al., 1994; Brown et al., 1998) . The mechanisms underlying interactions of ONOOwith platelets are not clear. It was hypothesized that
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T. Rusak and others ONOO -may affect platelets through the nitration of protein tyrosine residues (Brown et al., 1998; Boulos et al., 2000) , but it soon appeared that nitrotyrosinecontaining proteins are found also in the cells activated by collagen, i.e. in the absence of exogenous peroxynitrite (Naseem et. al., 2000) . It has also been proposed that in the presence of naturally occurring SH-containing compounds (e.g. glutathione) ONOOcan be converted to nitrosothiols, which may act as NO donors. Thus produced NO was suggested to inhibit platelet responses via the stimulation of soluble guanylate cyclase (Brown et al., 1998) . It was also reported that ONOO -might affect platelets nonspecifically via peroxidation of membrane lipids (Nowak & Wachowicz, 2001) . Studies performed on cells other then platelets have shown that ONOO -may strongly diminish mitochondrial respiration (Radi et al., 2002) . Platelets possess mitochondria and oxidative energy production in resting (unstimulated) cells provides up to 50% of the total ATP formed (Holmsen, 1981) . Metabolically, platelets are relatively active and have a total ATP turnover rate of about 3-8 times that of resting mammalian muscle (Akkerman 1978; Akkerman et al., 1978; Niu et al., 1996) . Unstimulated platelets use the energy in the processes enabling them to be permanently in the responsive state. In activated platelets metabolic energy is required mainly for secretion and aggregation (Holmsen, 1981) . Therefore the inhibition of platelet energy production may have critical implications for their responses (Holmsen et al., 1982; Verhoeven et al., 1984; Guppy et al., 1995) . Consequently, the present study was performed to test the hypothesis that ONOO -may affect platelet responses through the inhibition of energy production.
MATerIAlS AND MeTHODS
Chemicals. Antimycin A, 2,4-dinitrophenol (DNP), 1H-[1,2,4]-oxadiazolo-[4,3-α]quinoxalin-1-one (ODQ), 8-bromoguanosine 3',5'-cyclic monophosphate (8-BrcGMP) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Collagen (fibrillar, from equine tendon) was from Hormon Chemie (Munich, Germany).
Synthesis of ONOO -. Peroxynitrite was synthesized by the reaction of acidified NaNO 2 (1.2 M) with H 2 O 2 (1.4 M) in a quenched flow reactor . The excess of H 2 O 2 was removed by passing of the product over a column filled with granular manganese dioxide. Stock solutions containing at least 200 mM ONOO -were prepared and stored at -70°C. The concentration was determined prior to each experiment by measuring the absorbance at 302 nm (ε 302 = 1670 M -1 cm -1 ). Decomposed ONOO -was obtained by allowing the compound to decay in 0.5 M phosphate buffer (pH 7.4) at 25°C for 30 min.
Preparation of platelet-rich plasma (PrP) and platelet-poor plasma (PPP). Blood was collected in the local slaughterhouse from adult pigs. The blood was withdrawn by direct carotid catheterization and collected into 3.8% (w/v) sodium citrate, one volume per nine volumes of blood. PRP was obtained by centrifugation of the blood at 200 × g for 20 min at room temperature. PPP was obtained by further centrifugation of PRP at 2700 × g for 10 min.
Preparation of platelet concentrate. Blood collected into ACD (0.075 M citric acid, 0.085 M sodium citrate and 0.11 M glucose) solution (one volume per six volumes of blood) was used to prepare platelet concentrate (Tomasiak et al., 2004) .
Preparation of platelet homogenates. Platelet homogenate was prepared from fresh blood as described previously (Tomasiak et al., 2004) .
Assay of platelet aggregation. Platelet aggregation was followed turbidimetrically by recording the light transmission through a stirred platelet suspension in the plastic cuvette of an aggregometer (Elvi, Logos, Milan, Italy) at 37°C (Born & Cross, 1963) . All experiments were performed at least in quadruplicate using six different platelet preparations.
Simultaneous measurement of platelet aggregation and ATP secretion. The platelet release reaction was monitored simultaneously with optical aggregation using lumiaggregometer (Chrono-log Corp., Havertown, PA, USA). All procedures were conducted as described previously (Tomasiak et al., 2004) . The chemiluminescence signal was converted to nanomoles ATP per 10 8 cells by comparison with an ATP standard curve.
Measurement of serotonin secretion. Secretion was determined by the release of [ 3 H]serotonin using a procedure described previously (Tomasiak et al., 2004) .
Measurement of glycolysis in intact platelets. Platelets (2 × 10 9 platelets/ml) suspended in dialyzed plasma were incubated at 37°C in plastic vessels (50 ml conical Falcon tubes) with gentle stirring under the atmosphere of 95% O 2 + 5% CO 2 . Every 5 min the pH of the incubation mixture was checked and, if necessary, corrected by the addition of 0.2 M NaOH (total volume of NaOH added never exceeded 5% of the volume of platelet suspension). Incubation was started by the addition of glucose to the final concentration of 10 mM and was carried out for 30 min. It was stopped by the addition of 3 volumes of cold 6% (w/v) perchloric acid. Lactate was measured in deproteinized and neutralized extract (Gutmann & Wahlefeld, 1985) . The formation of lactate was found to be linear during 30 min of incubation.
ONOO -and platelet energy metabolism
Measurement of glycolysis in cell-free system. Platelets obtained from 2 l of blood were suspended in 20 ml of dialyzed plasma. The concentrate was cooled to 0°C, supplemented with dithiothreitol (1.5 mM final concentration) and disrupted sonically. Immediately after sonication samples were used for the measurement of glycolytic activity (Tomasiak et al., 2004) .
Measurement of the respiration rate. Respiration was measured polarographically at 37°C with a Clark-type oxygen electrode (Yellow Springs, USA, model YSI 4004) in a closed plastic vessel of 2 ml.
Measurement of intracellular ATP. After incubations platelet suspensions (1 ml) were supplemented with 3 ml of ice cold 6% (w/v) perchloric acid, sonicated and left at 0°C for 20 min. The extracts were centrifuged to remove protein and neutralized with ice cold 6 M KOH/0.5 M morpholine sulphonic acid. ATP content was determined in neutralized cellular extracts by the luciferase-luciferin assay (Holmsen et al., 1972) .
Assays of succinate dehydrogenase, NADH : ubiquinone oxidoreductase, cytochrome c oxidase activities were performed as described previously (Tomasiak et al., 2004) .
Data analysis. Data reported in this paper are the mean (± S.D.) of the number of determinations indicated (n). Statistical analysis was performed by the Student's t-test and elaboration of experimental data by the use of Slide Write plus (Advanced Graphics Software, Inc. Carlsbad, CA, USA.) reSUlTS Figure 1 illustrates the results of experiments in which the effect of increasing concentrations of ONOO -on collagen-induced platelet aggregation and dense granule secretion was studied. Dense granule secretion was determined using two independent methods, i.e. by luminometry which measured the ATP (nonmetabolic pool of nucleotide normally stored in dense granules) released from dense granules, and an isotopic method which determined the release of [ 3 H]serotonin (stored in dense granules) from the platelets preloaded with tritiated serotonin. As it is seen, a two-minute incubation of platelets with ONOO -(25-300 µM) inhibited, in a dose dependent manner, the aggregation and dense granule secretion induced by a threshold concentration of collagen. The estimated IC 50 values for aggregation, ATP release and serotonin secretion were 124 ± 18, 55 ± 7, and 58 ± 8 µM, respectively. Total inhibition of aggregation and secretion was observed in the presence of 250-300 µM ONOO -.
Experiments shown in Table 1 were performed to compare the susceptibility of (collageninduced) platelet aggregation and secretion to the inhibition by ONOO -and a respiratory chain blocker, antimycin A. Platelet responses were measured in PRP samples using a lumiaggregometer. Aggregation and secretion of ATP from platelet dense granules were recorded simultaneously in the same platelet sample. Treatment of platelets with 100 µM ONOO -resulted in a distinctly stronger inhibition of secretion (about 60%) than aggregation (about 30%). Similar results were obtained following the blocking of mitochondrial energy production by antimycin A. In this case pretreatment with 10 µM antimycin A produced 25% and 75% inhibition of aggregation and secretion, respectively.
To estimate whether the inhibitory effect of ONOO -on platelet responses is mediated by NOstimulated guanylate cyclase (sGC) we studied the effect of ODQ, an inhibitor of sGC, on the antiaggregatory and antisecretory action of ONOO -in collagen-stimulated platelets. As is seen in Table 1 (panel B) concentrations of ODQ nearly completely reducing the antiaggregatory effect of sodium nitroprusside (NO donor) only slightly abolished the ONOO -effect on secretion (about 5%) and aggregation (about 11%).
The results presented in Table 2 show that the rate of glycolysis in intact platelets was increased by ONOO -(25 to 300 µM), respiratory chain blockers (cyanide, antimycin A), an uncoupler (2,4-dinitrophenol), and following activation of platelets by collagen. Decomposed ONOO -(300 µM) did not Aliquots (0.5 ml) of PRP or washed platelets were incubated for 2 min at 37°C without (control) or with ONOOadded to the final concentration as indicated. The extent of platelet aggregation (u), ATP secretion (¨) and release of [ 3 H]serotonin (¡) were measured 3 min after the addition of the threshold concentration of collagen (15-20 µg/ ml). Decomposed ONOO -(300 µM) exerted no observable effect on collagen-induced aggregation and dense granule secretion. Aggregation, ATP secretion and [ 3 H]serotonin release were monitored as under Methods. All experiments were performed at least in quadruplicate using five different platelet preparations. Means ± S.D. are presented. The differences between the control and ONOO --treated platelets are significant. **P < 0.05; ***P < 0.01. affect glycolysis in intact platelets. The stimulatory effect of ONOO -on glycolysis was similar to that observed after the blocking of the respiratory chain by antimycin A or cyanide and to that produced by aggregating concentrations of collagen and was not abolished after the blocking of guanylate cyclase by ODQ. The rate of glycolysis in intact platelets was not affected following the treatment of the cells with 8-bromoguanosine 3',5'-cyclic monophosphate, a lipid-soluble analog of cGMP (Corbin et al., 1986 ) and a specific stimulator of protein kinase G (Lincoln & Corbin, 1983) To establish how ONOO -affects glycolysis in a cell-free system, i.e. in a system containing all the glycolytic enzymes and depleted of intact mitochondria, we measured the effect of ONOO -on lactate production in platelet homogenate. Platelet homogenate was used instead of a high-speed supernatant fraction (cytosol) since, as established by Akkerman (1978) , 97% of the total hexokinase activity in platelets is membrane bound (mitochondria). Respiratory chain blockers (cyanide, antimycin A), uncouplers (2,4-dinitrophenol) and ONOO -(50-300 µM) did not affect the glycolysis rate measured in the cell-free system (not shown). Table 3 shows that respiratory chain blockers (cyanide and antimycin A) and ONOO -(50-300 µM) inhibited the oxygen consumption by unstimulated platelets. The effect exerted by ONOO -was dosedependent. The degree of this inhibition was similar to that observed in the presence of cyanide or antimycin A. In comparison to resting cells, collagenstimulated platelets demonstrated two times faster oxygen consumption. Decomposed ONOO -(300 µM) did not affect the oxygen consumption by intact platelets. The inhibitory effect of ONOO -on respiration was not abolished following the blocking of guanylate cyclase by ODQ. In resting platelets a rise in the intracellular cGMP concentration evoked by a lipid-soluble analog (8-BrcGMP) did not modulate changes in oxygen consumption. Table 4 illustrates the results of experiments which were performed to estimate whether in platelets ONOO -affects intracellular ATP content. As is seen, ONOO -(100-300 µM) failed to affect distinctly the intracellular ATP content in resting cells and in platelets activated by collagen. By contrast, in collagen-stimulated platelets pretreated with 200 µM ONOO -, a significant (about 30%) reduction of intracellular ATP content was observed. Decomposed (100 µM) 66.9 ± 8.5*** 38.4 ± 6.7*** ONOO -(150 µM) 39.6 ± 9.2*** 21.1 ± 6.4*** Antimycin (5 µg/ml) 92.2 ± 7.6* 52.6 ± 6.1*** Antimycin (10 µg/ml) 89.6 ± 8.1** 39.7 ± 7.1*** Antimycin (20 µg/ml) 74.8 ± 7.1*** 24.9 ± 5.2*** B ONOO -(150 µM) 41.6 ± 9.4*** 23.6 ± 4.6*** ONOO -(150 µM)+ODQ (20 µM) 52.8 ± 7.5*** 28.7 ± 4.8*** SNP (25 µM) 44.4 ± 8.6*** n.d. SNP (25 µM) + ODQ (10 µM) 95.6 ± 4.4 n.d. PRP (0.5 ml) was incubated at 37°C for 2 min, without (control) or with tested substances added to the final concentrations as indicated. Aggregation and secretion were initiated by the addition of a supra-threshold concentration of collagen (20 µg/ml). Optical aggregation and dense granule secretion were monitored simultaneously as in Methods. The data represent mean values ± S.D. of five experiments, each performed on separate platelet preparation (n = 15). *P < 0.05, **P < 0.01, ***P < 0.005. (n = 6) of one representative (out of six) experiment performed on single platelet preparation. Lactate production in the control varied from 2.7 to 3.8 µmoles × min -1 × 10 -11 cells. *P < 0.05, **P < 0.01, ***P < 0.001.
ONOO -did not affect the intracellular ATP concentration in resting or collagen-stimulated cells. Table 5 demonstrates the results of experiments in which the effect of ONOO -on the activity of NADH : ubiquinone oxidoreductase, succinate dehydrogenase and cytochrome oxidase in platelet homogenate was studied. ONOO -(50-300 µM) reduced, in a concentration-dependent fashion, the activity of all the enzymes studied. The sensitivity of the enzymes to ONOO -increased in the following order: cytochrome oxidase < succinate dehydrogenase < NADH : ubiquinone oxidoreductase. Thus, 200 µM ONOO -inhibited cytochrome oxidase, succinate dehydrogenase and NADH : ubiquinone oxidoreductase by about 12%, 20% and 33%, respectively.
DISCUSSION
The results presented here show that ONOOis a strong inhibitor of aggregation and secretion of porcine platelets. This is in agreement with previous reports (Moro et al., 1994; Nowak & Wachowicz, 2001 ). It has been reported that activation of human platelets by high thrombin concentration is accompanied by the acceleration of lactate production and enhanced oxygen consumption (Akkerman & Holmsen, 1981; Niu et al., 1996) . Our results show that porcine platelets stimulated by collagen also produce more lactate and consume more oxygen indicating that both glycolytic and mitochondrial ATP production are necessary to support their responses. This implies that in platelets blocking of energy production is likely to diminish their responses.
The present results show, for the first time, that under aerobic conditions exogenously added ONOO -stimulates glycolysis in intact porcine platelets. The degree of this stimulation was similar to that observed after the blocking of mitochondrial energy production by an uncoupler (dinitrophenol) or Oxygen consumption was measured polarographically with a Clark oxygen electrode, in a closed plastic vessel of 2 ml at 37°C. Aliquots (1 ml) of platelet concentrate and 1 ml of dialyzed plasma were added to the vessel to give the final concentration of 2 × 10 9 cells/ml. Measurements were started after 2 min preincubation and were carried out for 10 min. Additions to the measuring system were done 3 min after starting the recording of oxygen consumption. No exogenous glucose was added. The results of one representative experiment (out of five) are presented. Oxygen consumption in the control varied from 320 to 440 nmol × min -1 × 10 -11 cells. **P < 0.05, ***P < 0.001. 2.69 ± 0.27 1.91 ± 0.36 *** 2.73 ± 0.31
Aliquots (1 ml) of PRP were incubated for 5 min at 37°C without (control) or with ONOO -added to the final concentration as indicated. ATP was measured in deproteinized and neutralized extracts as described under Methods. The data represent mean values ± S.D. of five experiments, each performed on separate platelet preparation (n = 15). *P < 0.05, ***P < 0.005. 17.6 ± 0.2 0.94 ± 0.05 3.07 ± 0.5 100 µM ONOO -13.5 ± 0.5 * 0.82 ± 0.04 ** 2.94 ± 0.4 200 µM ONOO -11.1 ± 1.2 *** 0.79 ± 0.04 ** 2.74 ± 0.5 ** 300 µM ONOO -9.6 ± 2.1 *** 0.67 ± 0.07 ** 2.21 ± 0.5*** Decomposed ONOO -(300 µM) 17.9 ± 0.3 0.96 ± 0.07 3.07 ± 0. by respiratory chain inhibitors (antimycin A or cyanide). At the same time ONOO -, dinitrophenol, antimycin A and cyanide had no effect on the rate of glycolysis in the platelet homogenate in which functional (coupled) mitochondria were apparently not present. Since in platelets glycolysis and mitochondrial respiration are tightly functionally connected (Guppy et al., 1995) , this can be interpreted to mean that the stimulatory effect of ONOO -on glycolysis in intact platelets may be related to impairment of mitochondria. This interpretation is likely to be true since, as reported here, in porcine platelets ONOOis able to reduce mitochondrial oxygen consumption and to inhibit NADH : ubiquinone reductase, succinate dehydrogenase and cytochrome oxidase. Interestingly, the concentrations of ONOO -inhibiting mitochondrial respiration and respiratory chain complexes were similar to those stimulating glycolysis in intact platelets.
To sum up, ONOO -is able to reduce platelet mitochondrial energy production through the inhibition of respiratory chain complexes I, II and IV.
The current observations indicate that in porcine platelets respiratory chain enzymes differ in their sensitivity to ONOO -, which increases in the order: cytochrome oxidase < succinate dehydrogenase < NADH : ubiquinone reductase. This is consistent with the observation of Riobo et al. (2001) that in rat brain submitochondrial particles, complex I (NADH : ubiquinone reductase activity) is much more sensitive to peroxynitrite than complexes II and III.
Our results indicate that the ONOO -concentrations totally blocking mitochondrial respiration are not able to inhibit completely the activity of respiratory chain enzymes. This indicates that peroxynitrite may affect platelet mitochondria not only through the inhibition of respiratory chain complexes. Thus, other damaging effects of ONOO -on platelet mitochondria are also likely to take place.
Activation of porcine platelets by collagen was not associated with a drop in the total cellular ATP content, despite the fact that aggregation and secretion are known to consume large quantities of metabolic energy (Holmsen et al., 1982) . This is because the accelerated oxidative and glycolytic ATP production have a capacity completely to meet the augmented (due to activation) energy demand. Also, no reduction in cellular ATP content was observed in resting platelets treated with ONOO -. In this case accelerated glycolysis apparently had the capacity to fully compensate the lack of mitochondrial energy production and to meet the relatively small cellular ATP demand expected in resting cells. This is consistent with the observation that in platelets incubated under hypoxic conditions cellular ATP level remained unchanged (Akahori et al., 1995) . However, as is here reported, a distinct reduction of cellular ATP content was observed in activated (by collagen) platelets pretreated with ONOO -. In this case even accelerated glycolytic ATP production failed to fully compensate for the impaired (by ONOO -) mitochondrial ATP production and to meet the high metabolic energy demand of activated cells (Akkerman & Holmsen, 1981) .
Does the ONOO --mediated blocking of mitochondrial energy production explain the inhibitory effect of this compound on in vitro platelet responses? As is shown here in porcine platelets, diminishing the mitochondrial energy production by antimycin A affects platelet secretion distinctly more strongly than aggregation. This is consistent with the suggestion that platelet responses have different metabolic energy requirements, which increase in the order: aggregation < dense and alpha granule secretion < lysosome secretion (Holmsen et al., 1982; Verhoeven et al., 1984; Morimoto & Ogihara, 1996) . A comparison of the concentrations of ONOO -affecting mitochondrial respiration with those reducing platelet aggregation and secretion indicates that ONOO -cannot reduce significantly platelet aggregation through the inhibition of oxidative energy production. By contrast, the concentrations of ONOO -inhibiting platelet secretion and mitochondrial respiration were similar. This and the observation that ONOO -inhibits dense granule secretion more strongly than aggregation implies that in porcine platelets ONOO -can affect the secretory process through the inhibition of mitochondrial energy production.
To sum up, the inhibitory effect of ONOO -on platelet secretion, and to a lesser extent on aggregation, may be related to the reduction of mitochondrial energy production.
ONOO -was also reported to react with intracellular components containing SH-groups (e.g. glutathione) and to form nitrosothiols (Mayer et al., 1995) . Nitric oxide released from spontaneously decomposed nitrosothiols was proposed to activate soluble guanylate cyclase (sGC) (Mayer et al., 1995) and to inhibit cytochrome oxidase (Brown, 2001) . The rise in intracellular cGMP level thus produced (Danielewski et al., 2005) and reduction of mitochondrial energy production (Tomasiak et al., 2004) have been proposed to inhibit platelet activation. However, the results presented here indicate that soluble guanylate cyclase is not a predominant intracellular factor mediating the ONOO -action on platelets, although its involvement in the inhibition of aggregation (but not secretion) can not be completely excluded (Table 1) . This is because blocking of the guanylate cyclase slightly affects ONOO -action on platelet aggregation and is practically without any effect on secretion. Guanylate cyclase cannot be in-volved in the inhibition of energy production either, since both glycolysis and mitochondrial respiration were not affected by an artificially elevated intracellular cGMP concentration. An involvement of NO in the ONOO -action on platelet cytochrome oxidase is also unlikely. A comparison of the ODQ (a guanylate cyclase inhibitor) effect on the antiaggregatory action of sodium nitroprusside (NO donor) and ONOO -indicates that in platelets treated with peroxynitrite, guanylate cyclase is not maximally activated apparently due to a lower NO concentration. Taking into account that NO inhibits purified sGC (from brain cells) at concentrations 50-100 lower then that required to inhibit cytochrome oxidase (Bellamy et al., 2002) , a nitric oxide-dependent ONOO -action on cytochrome oxidase is also excluded.
In conclusion, our data show that: 1) in porcine platelets ONOO -is able to diminish mitochondrial respiration through the inhibition of respiratory chain complexes I, II and IV; 2) the inhibitory effect of ONOO -on platelet secretion (but not aggregation) can be attributed, at least in part, to the reduction of mitochondrial energy production.
